Patricia A. Rayman
Impact in
- Immunology top 0.5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 54
- Immunotherapy and Immune Responses 21
- Immune Cell Function and Interaction 18
- Immune cells in cancer 15
- T-cell and B-cell Immunology 7
- Oncology 35
- Cancer Immunotherapy and Biomarkers 24
- CAR-T cell therapy research 9
- Co-authors
- James H. Finke (64 shared papers)Ronald M. Bukowski (36 shared papers)Brian I. Rini (17 shared papers)Joanna L. Ireland (5 shared papers)Jennifer S. Ko (16 shared papers)Paul J. Elson (10 shared papers)Laura S. Wood (3 shared papers)Peter A. Cohen (5 shared papers)
- Journals
- The Journal of Immunology (7 papers)Clinical Cancer Research (6 papers)Journal for ImmunoTherapy of Cancer (5 papers)Cancer Research (5 papers)Journal of Immunotherapy (5 papers)
- Partner nations
- United StatesIndiaSpain
In The Last Decade
Patricia A. Rayman
77 papers receiving 4.9k citations
Patricia A. Rayman's Hit Papers
Peers
Comparison fields: 5 of 94
- Immunology 2.9k
- Oncology 2.2k
- Cancer Research 678
- Genetics 286
- Pulmonary and Respiratory Medicine 812
Countries citing papers authored by Patricia A. Rayman
This map shows the geographic impact of Patricia A. Rayman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia A. Rayman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia A. Rayman more than expected).
Fields of papers citing papers by Patricia A. Rayman
This network shows the impact of papers produced by Patricia A. Rayman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia A. Rayman. The network helps show where Patricia A. Rayman may publish in the future.
Co-authors
The 25 scholars most cited alongside Patricia A. Rayman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients Hit paper breakdown → | 2009 | 744 |
| 2 | Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients Hit paper breakdown → | 2008 | 423 |
| 3 | 2011 | 306 | |
| 4 | 2010 | 240 | |
| 5 | 2016 | 217 | |
| 6 | 2016 | 190 | |
| 7 | 2016 | 170 | |
| 8 | 2015 | 125 | |
| 9 | Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. | 1999 | 124 |
| 10 | 2005 | 117 | |
| 11 | 1999 | 115 | |
| 12 | Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. | 1999 | 97 |
| 13 | 2021 | 92 | |
| 14 | Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma. | 1991 | 87 |
| 15 | 1992 | 86 | |
| 16 | 1999 | 86 | |
| 17 | Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. | 1990 | 81 |
| 18 | 2018 | 80 | |
| 19 | 2006 | 79 | |
| 20 | T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report. | 1994 | 76 |
About Patricia A. Rayman
Patricia A. Rayman is a scholar working on Immunology, Oncology, Cancer Research, Molecular Biology and Neurology, having authored 80 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (18 papers), Immune cells in cancer (15 papers), CAR-T cell therapy research (9 papers), Cell death mechanisms and regulation (9 papers), NF-κB Signaling Pathways (9 papers) and T-cell and B-cell Immunology (7 papers). The work is most often cited by research in Immunology (2.9k citations), Oncology (2.2k citations), Cancer Research (678 citations), Genetics (286 citations) and Pulmonary and Respiratory Medicine (812 citations). Patricia A. Rayman has collaborated with scholars based in United States, India and Spain. Frequent co-authors include James H. Finke, Ronald M. Bukowski, Brian I. Rini, Joanna L. Ireland, Jennifer S. Ko, Paul J. Elson, Laura S. Wood, Peter A. Cohen, Charles S. Tannenbaum and Robert Dreicer. Their work appears in journals such as The Journal of Immunology, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer, Cancer Research and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.